The IBN SINA Pharmaceutical Industry Ltd. reported earnings results for the full year ended June 30, 2021. For the full year, the company reported sales was BDT 7,376.04 million compared to BDT 6,191.63 million a year ago. Net income was BDT 489.12 million compared to BDT 392.53 million a year ago. Basic earnings per share from continuing operations was BDT 15.66 compared to BDT 12.56 a year ago.